XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stock Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract] |
Stock Based Compensation | STOCK BASED COMPENSATION On May 13, 2021, the Company’s stockholders approved the 2021 Long Term Equity Incentive Plan and, on May 14, 2024, the Company’s stockholders approved an amendment to the 2021 Long Term Equity Incentive Plan (as amended, the “2021 Plan”). The 2021 Plan replaced the 2006 Long Term Equity Incentive Plan (the “2006 Plan”) approved in May 2006 and amended in May 2015. The 2021 Plan allows for grants to employees, officers, non-employee directors, consultants, independent contractors and advisors of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based awards (“stock awards”) up to an aggregate of 1,094,823 shares for issuance. At June 30, 2024, 322,498 shares of common stock were available for issuance under the 2021 Plan. Awards can be granted under the 2021 Plan through the earlier of May 13, 2031, or the date the maximum number of available shares under the 2021 Plan have been granted. Awards under the 2021 Plan vest over one to three years and shares previously awarded and currently unvested under the 2006 Plan vest over three years. Shares granted under the 2021 Plans vest immediately upon the date of a participant’s death, disability or change in control. The Company follows the provisions of FASB ASC 718 requiring that compensation cost relating to share-based payment transactions be recognized in the financial statements. The cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the employee's requisite service period (generally the vesting period of the equity award). During the six months ended June 30, 2024 employees withheld 71,350 shares of the Company's common stock to satisfy income withholding obligations in connection with the vesting of restricted awards, and in the same period in 2023 the Company withheld 95,897 shares. Restricted Stock The Company grants shares of its common stock to certain directors, officers, key managers and employees in the form of unvested stock and units (“Restricted Stock”). These awards are measured at the fair value of the Company's common stock on the date of issuance and recognized ratably as compensation expense over the applicable vesting period, which is typically three years. The Company adjusts compensation expense for actual forfeitures, as they occur. The following summarizes the status of Restricted Stock and changes during the six months ended June 30, 2024:
| Number of Shares |  | Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2023 | 373,583 |  |  | $ | 12.81 |
Granted | 94,704 |  |  | 19.18 |
Vested | (199,359) |  |  | 13.22 |
Forfeited | — |  |  | — |
Unvested balance at June 30, 2024 | 268,928 |  |  | $ | 15.49 |
At June 30, 2024 and 2023, there was $3,471,000 and $4,398,000, respectively, of total unrecognized compensation expense, related to Restricted Stock grants. The unrecognized compensation expense at June 30, 2024 is expected to be recognized over the weighted-average period of 1.9 years. Total compensation cost related to Restricted Stock grants for the three months ended June 30, 2024 and 2023 was $705,000 and $741,000, respectively. Total compensation cost related to Restricted Stock grants for the six months ended June 30, 2024 and 2023 was $1,413,000 and $1,466,000 all of which was recorded to selling, general and administrative expense. Performance Restricted Stock Awards The Company grants shares of its common stock to certain officers and key managers in the form of shares of performance-based restricted stock ("Performance Restricted Stock Awards"). These awards are measured at the fair value of the Company's common stock on the date of issuance and recognized ratably as compensation expense over the applicable vesting period to the extent that the performance measures have been satisfied as of the last day of the performance period of the award. The total amount payable as of the award's vesting date is determined by the three year average Operational Income and Return on Capital Employed performance measure achievement. The Company adjusts compensation expense for actual forfeitures as they occur, and for estimated performance measure achievement. The following summarizes the status of Performance Restricted Stock Awards and changes during the six months ended June 30, 2024:
| Number of Shares |  | Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2023 | 11,737 |  |  | $ | 15.98 |
Granted | 28,483 |  |  | 19.18 |
Vested | — |  |  | — |
Forfeited | — |  |  | — |
Unvested balance at June 30, 2024 | 40,220 |  |  | $ | 18.24 |
At June 30, 2024 and 2023, there was $590,000 and $167,000 of total unrecognized compensation expense related to Performance Restricted Stock Awards. The unrecognized compensation expense at June 30, 2024 is expected to be recognized over the weighted-average period of 2.5 years. Total compensation cost related to Performance Restricted Stock Awards for the three months ended June 30, 2024 and 2023 was $61,000 and $15,000, respectively. Total compensation cost related to Performance Restricted Stock grants for the six months ended June 30, 2024 and 2023 was $92,000 and $21,000, respectively all of which was recorded to selling, general and administrative expense. Stock Repurchase Plan On March 11, 2024, the Company announced that its Board of Directors approved a stock repurchase program authorizing the Company to repurchase up to $7,500,000 of its outstanding shares of common stock. Repurchases of shares of common stock under the stock repurchase program are made in the open market and in accordance with applicable securities laws. The stock repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion. There were 23,989 shares repurchased under the repurchase program during the three months ended June 30, 2024, totaling $393,000.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration